A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2001
11/15/2001	WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2001001995A3 Method for treatment of asthma syndrome
11/15/2001	US20010041679 Multiple site delivery of adenoviral vector for the induction of angiogenesis
11/15/2001	US20010041342 Using apoptosis inhibiting protein
11/15/2001	US20010041212 Mixture of zinc and peptide
11/15/2001	US20010041174 Use of implanted encapsulated cells expressing glutamate transporter proteins for the treatment of neurodegenerative diseases
11/15/2001	US20010041173 Helper-dependent cloning vectors where most viral genes have been removed and have increased safety and capacity for larger insertions
11/15/2001	CA2776904A1 A device for forming or increasing the number of undifferentiated cells
11/15/2001	CA2409679A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	CA2409150A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408544A1 Combined marine and plant extract compositions
11/15/2001	CA2408352A1 Nontoxic vernix compositions and method of producing
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408196A1 Sphingosine kinase and uses thereof
11/15/2001	CA2408112A1 Skin protectant spray compositions
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2379088A1 Treatment of il-10 deficiencies
11/14/2001	EP1153131A2 Peroral gene therapy of diabetes and obesity
11/14/2001	EP1153123A2 Pluripotential cells-2
11/14/2001	EP1153122A2 Maturation of dendritic cells with immune response modifying compounds
11/14/2001	EP1153036A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
11/14/2001	EP1152773A1 Methods of inactivating pathogens using broad-spectrum pulsed light
11/14/2001	EP1152771A2 Adjuvant and cell maturation agent
11/14/2001	EP1152768A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
11/14/2001	EP1152767A2 Method for producing anti-tumor th1 cells
11/14/2001	EP1152731A1 A skin care composition that mediates cell to cell communication
11/14/2001	EP1003537B1 Composition comprising propolis and at least an essential oil
11/14/2001	EP0980250B1 Plant extracts for the treatment of increased bone resorption
11/14/2001	EP0831861A4 Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures
11/14/2001	EP0688360B1 Bone stimulating factor
11/14/2001	EP0652900B1 Thrombin inhibitors
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1322214A Induction of antiobiotic proteins and peptides by LAIT/sCD14-protein
11/14/2001	CN1321513A Medicine and food dual-purpose enriched nutrient for resisting AIDS
11/14/2001	CN1321512A Ebikang medicine for treating nasal disorders and its preparation method
11/14/2001	CN1321510A Chinese medicine for curing gastropathy and its preparation method
11/14/2001	CN1321507A Chinese medicine for curing rheumatoid disease and preparing method thereof
11/14/2001	CN1321504A Jingzhuikang medicine for curing cervical spondylopathy
11/14/2001	CN1321502A Dankang medicine for curing cholecystopathy
11/14/2001	CN1321499A Chinese patent medicine for curing deafness
11/14/2001	CN1321498A Medicine for curing acne and sore
11/14/2001	CN1321493A Chinese medicine capsule for curing prolapse of lumber intervertebral disc and preparing method thereof
11/14/2001	CN1321491A Medicine for curing male infertility and female sterility
11/14/2001	CN1321490A Chinese medicine for external application-longfenggao for curing infertility and its preparation method
11/14/2001	CN1321487A Beauty face-nourishing capsule
11/14/2001	CN1321479A Chinese medicine preparation for curing hematopathy
11/14/2001	CN1321470A Method for preparing genetic antibiotic peptide medicine for animals from transgenic antibiotic peptide muscidian vermicule and its application
11/14/2001	CN1321469A Pinctada martensii visceral organs glycoprotein and glycosaminoglycan with tumor-resisting activity and their extraction process
11/14/2001	CN1321468A Freeze-dried plasma without blood group and its preparation method
11/14/2001	CN1321467A Fresh refrigerated plasma without blood group
11/14/2001	CN1074678C Preparation method of external-applied chinese herbal medicine plaster for treating hepatitis B
11/14/2001	CN1074674C Medicinal composition for curing and preventing urinary calculus
11/14/2001	CN1074671C Medicinal pollen for treating cancer
11/14/2001	CN1074668C Preparation of termite and earthworm
11/13/2001	US6316692 Insertion of nucleotide sequences into genomes; inject sample into testes, recover preferential polypeptide from transformed cells
11/13/2001	US6316492 Methods for treating or preventing viral infections and associated diseases
11/13/2001	US6316256 Method for protein transfer
11/13/2001	US6316254 Methods for stimulating erythropoiesis using hematopoietic proteins
11/13/2001	US6316250 Molecular clones producing recombinant DNA antigens of the hantavirus-associated respiratory distress (HARDS)
11/13/2001	US6316214 ETM-775 metabolite of ecteinascidin 743
11/13/2001	US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316001 Method for treatment of psoriasis
11/13/2001	US6315994 Providing pancreatic tissue comprising islet cells and acinar cells; encapsulating in matrix comprising gelatin and polar amino acid selected from arginine, lysine, histidine, glutamic acid, and aspartic acid; introducing transplant into host
11/13/2001	US6315992 Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-β-1
11/13/2001	US6315706 Method for separating cells, especially platelets, and bag assembly therefor
11/13/2001	US6314956 Treating lung defects associated hypoxemia or smooth muscle constriction; administer ethyl nitrite to human and monitor
11/11/2001	CA2308105A1 Treatment of il-10 deficiencies
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083731A1 Methods and compositions for producing donor cells
11/08/2001	WO2001083729A2 Vectors for ocular transduction and use thereof for genetic therapy
11/08/2001	WO2001083716A2 Immortalized lines of endothelial brain cells and therapeutic application thereof
11/08/2001	WO2001083715A2 Derivation of midbrain dopaminergic neurons from embryonic stem cells
11/08/2001	WO2001083712A1 Method of forming vertebrate pancreas in vitro
11/08/2001	WO2001083711A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
11/08/2001	WO2001083710A2 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	WO2001083709A1 Isolation of mesenchymal stem cells and use thereof
11/08/2001	WO2001083707A2 Chondrocyte cultures and anti-angiogenic fractions therefrom
11/08/2001	WO2001083704A1 Spray-dried microbial cells
11/08/2001	WO2001083700A2 Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083692A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	WO2001083562A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/08/2001	WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001082939A1 Treatment of conditions of the central nervous system using mycobacteria
11/08/2001	WO2001082828A2 Tissue engineered testicular prosthesis and use thereof
11/08/2001	WO2001082773A2 Structures useful for bone engineering and methods
11/08/2001	WO2001082699A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	WO2001041801A3 Mutant simplex virus for treating unwanted hyperproliferative cell growth
11/08/2001	WO2001041776A3 Use of honey in medical dressings
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001032128A3 Human chemokine beta-13

1 ... 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 ... 1259